Stifel Remains a Buy on Artivion (AROT) [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
Artivion, Inc. (NYSE: AORT ) is one of the Best Small-Cap Growth Stocks to Buy According to Hedge Funds . On March 5, Artivion, Inc. (NYSE:AORT) was reiterated with a Buy rating by analyst John McAulay of Stifel with a price target of $55. ?The analyst said in a research note that the Buy rating is based on the company's promising aortic disease pipeline. He highlighted Artivion's NEXUS stent graft system as the next key launch for treating chronic aortic arch dissections and aneurysms, estimating a $150 million US total addressable market. The analyst noted that the one-year results from the NEXUS TRIOMPHE pivotal trial were shared at the Society of Thoracic Surgeons meeting in late January 2026. The data showed strong sealing performance and low endoleak rates. Stifel Remains a Buy on Artivion (AROT) Copyright: nimon / 123RF Stock Photo ?The analyst interviewed three physicians experienced with NEXUS implants who intend to adopt it post-FDA approval. These discussions evalu
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- 3 of Wall Street's Favorite Stocks We Steer Clear Of [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT) was given a new $55.00 price target by Stifel Nicolaus.MarketBeat
- Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services ConferencePR Newswire
- Artivion (NYSE:AORT) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "sell (d)" rating to a "hold (c-)" rating.MarketBeat
- Why Artivion (AORT) Is Down 7.6% After Mixed Q4 Results And 2026 Guidance Above Consensus [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 2/12/26 - Beat
AORT
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- AORT's page on the SEC website